CVEvulnerability
CVE-2026-34323
6.3 MEDIUM
Official page ↗
- Status
- Analyzed
- Published
- 2026-04-21
- Last modified
- 2026-10-26
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 6.3 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L
- Weaknesses
- CWE-284
Description
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).
Affected configurations
• oracle life sciences inform 7.0.1.0
• oracle life sciences inform 7.0.1.1
Related
Weakness · CWE (1)
- CWE-284 Improper Access Control weakness
References
- https://www.oracle.com/security-alerts/cpuapr2026.html Vendor Advisory